重组胶原蛋白行业深度系列（一）：重组胶原蛋白商业化提速，中国成分踏入“黄金时代”-20231127-国金证券-39页_4mb

Summary of Analysis on Recombinant Collagen Industry

The recombinant collagen industry is poised for significant growth, driven by advanced recombinant technology that offers superior performance over animal-derived collagen in applications like skincare, aesthetics, and biomedical materials. Key benefits include enhanced biocompatibility, higher water solubility, and reduced immunogenicity, making recombinant collagen ideal for facial anti-aging, intimate health, and tissue engineering. Current market developments focus on rapid commercialization in skincare and aesthetics, with emerging applications in fillers and bioplastics.

Market projections indicate substantial growth, with the 2025 medical aesthetics facial market potentially reaching 102 billion yuan under neutral assumptions, and the 2030 vaginal rejuvenation market could exceed 70 billion yuan. Leading companies like Jiuzi Biotech, Jincibo Biotech, and R Beatwaters are pioneering innovations, with several achieving third-class medical device approvals. Despite these advancements, risks include technological hurdles, regulatory delays, and market adoption challenges.

This summary highlights the industry's potential, key drivers, competitive landscape, and risks based on industry trends and company profiles.